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Abstract
Plants, bacteria, fungi, and yeast utilize organic iron chelators (siderophores) to establish commensal and pathogenic relationships with
hosts and to survive as free-living organisms. In Gram-negative bacteria, transport of siderophores into the periplasm is mediated by TonB-
dependent receptors. A complex of three membrane-spanning proteins TonB, ExbB and ExbD couples the chemiosmotic potential of the
cytoplasmic membrane with siderophore uptake across the outer membrane. The crystallographic structures of two TonB-dependent receptors
(FhuA and FepA) have recently been determined. These outer membrane transporters show a novel fold consisting of two domains. A 22-
stranded antiparallel h-barrel traverses the outer membrane and adjacent h-strands are connected by extracellular loops and periplasmic turns.
Located inside the h-barrel is the plug domain, composed primarily of a mixed four-stranded h-sheet and a series of interspersed a-helices.
Siderophore binding induces distinct local and allosteric transitions that establish the structural basis of signal transduction across the outer
membrane and suggest a transport mechanism.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Iron has played an essential role in the evolution of life
on earth, and is required by most microorganisms [1]. As a
transition element, iron can reversibly modify its oxidation
state (Fig. 1). The ability to lose or gain a single electron
generates a wide range of favorable reduction–oxidation
potentials. Accordingly, this essential trace element is often
used as a cofactor in key metabolic processes, including
deoxyribonucleotide synthesis, oxidative phosphorylation,
and electron transport [2]. Despite its relative abundance in
nature, atmospheric oxygen rapidly oxidizes iron to form
stable, but sparingly soluble, ferric oxyhydroxides. As a
result, the concentration of biologically available iron may
be as low as 10 18 M under physiological conditions [3].
To colonize iron-restricted regions within hosts and to
satisfy their nutritional requirement, bacteria have devel-
oped extensive siderophore-mediated iron acquisition strat-
egies [4]. Under iron-limiting conditions, most bacteria
secrete at least one siderophore. These low molecular
weight compounds (500–1500 Da) can be divided into
three groups based on chemical composition: (i) catechols
(e.g. enterobactin); (ii) hydroxycarboxylates (e.g. citrate);
and (iii) hydroxamates (e.g. ferrichrome). Of the approx-
imately 200 known siderophores, most possess three biden-
tate iron chelating groups [3]. Although these agents display
considerable structural diversity, all form six coordinate
complexes with ferric iron of extraordinary affinity (for-
mation constants range from c 1023 to 1049).
Siderophores avidly scavenge ferric ions and are bound
by specific outer membrane receptors with high affinity
(Kdf 0.1 AM). In contrast to porins which utilize passive
diffusion for solute uptake, outer membrane receptors
actively pump siderophores into the periplasm against a
concentration gradient by utilizing an energy-dependent
transport mechanism. Gram-negative bacteria have multi-
ple siderophore-mediated iron acquisition pathways con-
sisting of an outer membrane receptor, a periplasmic
binding protein, and a complex of one or two cytoplasmic
membrane proteins with an associated ATP-binding cas-
sette, which together form an ABC transporter. Most
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bacteria express parallel systems each specific for a single
siderophore, underscoring the redundancy of these sys-
tems, their biological significance, and their importance in
establishing infection and virulence. Although Escherichia
coli encodes the genes for the biosynthesis of a single
endogenous siderophore (enterobactin), this bacterium also
Fig. 1. The Fenton and Haber–Weiss reactions coordinate the reduction of FeIII (ferric) to FeII (ferrous) iron in the presence of hydrogen peroxide with the
production of molecular oxygen, hydroxyl anions, superoxide and hydroxyl radicals [4]. Unregulated intracellular iron metabolism causes lipid peroxidation,
oxidation of sulfhydryl groups, DNA-damaging lesions, membrane disruptions, and ultimately, cell death. Superoxide dismutases normally degrade superoxide
radicals [66]. Peroxide anions are subsequently converted into molecular oxygen and water by catalases and peroxidases. These systems protect bacteria against
potent oxidizing agents that are generated either endogenously during respiration or exogenously by host organisms [67].
Fig. 2. Select siderophore-mediated iron acquisition systems of E. coli. Ligand transport across the outer membrane is TonB-dependent and requires the
chemiosmotic potential of the cytoplasmic membrane. Hydroxamates—FhuA transports ferrichrome, ferricrocin, and the antibiotics albomycin, rifamycin
CGP4832 and antibiotic microcin J25 [68]. Catechols—FepA transports ferric enterobactin [18]. Hydroxycarboxylates—FecA transports ferric citrate [61].
Cyanocobalamin (vitamin B12 contains cobalt) is grouped with those for siderophores, as they share a similar organization of proteins and utilize an analogous
mechanism of ligand transport. The vitamin B12 receptor in the outer membrane of E. coli is BtuB [20].
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utilizes siderophores secreted by co-existing microbes. For
example, the ferric hydroxamate uptake system allows E.
coli to utilize the fungal siderophore ferrichrome as an iron
source.
All siderophore-mediated iron acquisition pathways are
arranged such that iron chelates are transported across the
outer membrane, periplasm, and the cytoplasmic mem-
brane in discrete steps. The proteins required for each
transport stage are localized to different cell envelope
compartments and have specific energetic requirements
(Fig. 2). Localized within the outer membrane is a diverse
family of outer membrane receptors that transport side-
rophores into the periplasm. Siderophore uptake across the
outer membrane is dependent upon the presence of a
complex of three cytoplasmic membrane proteins TonB,
ExbB and ExbD, and their ability to couple a proton
gradient with siderophore transport [5]. Hence, this family
of active outer membrane transport proteins has been
termed TonB-dependent receptors.
The aim of this review is to provide an analysis of the
relationship between the three-dimensional structure of the
ferrichrome receptor FhuA and the ferric enterobactin
receptor FepA, and their biological function as TonB-
dependent transporters in the outer membrane of E. coli
[6,7]. A discussion of the TonB–ExbB–ExbD complex
and its role in energy transduction will also be presented.
2. Molecular architecture
The three-dimensional structures of unliganded FhuA
[8,9] and unliganded FepA [10], and FhuA in complex
with various siderophores [8,9,11] and antibiotics [11,12]
have recently been determined by X-ray crystallography
(Table 1). Both receptors show similar molecular architec-
tures composed of two domains (Figs. 3 and 4). Embedded
within the outer membrane is a monomeric C-terminal h-
barrel with a shear number of 24 [13]. Formed by 22
antiparallel h-strands, the barrel is approximately 70 A˚ in
height (Table 1). The right-handed twist of the h-strands
produces an elliptical-shaped barrel with a diameter of
35 47 A˚ (measured between equivalent Ca-positions on
opposite h-strands). Adjacent h-strands are connected by
11 long solvent-accessible loops at the external membrane
surface and 10 short turns directed toward the periplasm.
The tilt of the h-strands relative to the barrel axis is
approximately 45j, and all transmembrane strands extend
beyond the outer leaflet of the bilayer (Figs. 3 and 4).
Table 1
Statistical comparison of the three-dimensional structures of FepA and FhuA as determined by X-ray crystallography
Structural FepA FhuA
Barrel residues/Total residues 571/723 553/714
Transmembrane b-strands (b1–b22)
Minimal length 6 7
Maximal length 20 25
Average length 12.5 14.4
Percentage of barrel (%) 48.0 57.1
Extracellular loops (L1–L11)
Minimal length 3 3
Maximal length 38 35
Average length 22.1 17.0
Percentage of barrel (%) 42.6 33.8
Periplasmic turns (T1–T10)
Minimal length 2 2
Maximal length 11 9
Average length 5.4 5.0
Percentage of barrel (%) 9.5 9.0
Crystallographic Unliganded Liganded
FepA FhuAa Ferrichrome Ferricrocina Phenylferricrocina Albomycina CGP4832a,b
Resolution (A˚) 2.40 2.50 and 2.75 2.60 2.70 2.95 3.10 2.90
Rwork/Rfree (%) 23.4/28.5 22.1/27.1 and 18.6/24.3 18.3/23.0 23.1/27.6 22.5/27.8 22.2/28.3 23.3/27.5
PDB code 1FEP [10] 1QFG [8,14] and 1BY3 [9] 1BY5 [9] 1QFF [8] 1QJQ [11] 1QKC [11] 1FI1 [14]
The crystallographic structure of FepA in complex with ferric enterobactin has not been described [10].
a These structures were determined in complex with a single lipopolysaccharide molecule non-covalently bound to the external membrane-embedded
surface of the receptor [8,11,12,14].
b CGP4832 is a potent functional derivative of the antibiotic rifamycin, and does not contain ferric iron [14]. A statistical comparison of FepA and FhuA to
other bacterial outer membrane proteins has been presented elsewhere [69].
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As observed with other integral outer membrane pro-
teins, two girdles of aromatic residues extend into the outer
membrane, inscribing a 25-A˚ hydrophobic band upon the
membrane-exposed surface of FhuA and FepA (Fig. 5).
The crystallographic structure of FhuA in complex with a
single non-covalently bound lipopolysaccharide molecule
shows electrostatic protein–lipid interactions between the
phosphorylated glucosamine moieties and van der Waals
contacts with the acyl chains of lipopolysaccharide [14].
These findings precisely define the membrane-embedded
and solvent-accessible surfaces of the receptor, thereby
orienting FhuA within the outer membrane.
Located within the h-barrels of FhuA and FepA is an
N-terminal domain, termed the plug (Fig. 4B). The plug
domain consists of a mixed four-stranded h-sheet with
short interspersed a-helices and connecting loops (Figs.
3A and 4B). The plane of the h-sheet is tilted by
approximately 45j relative to the membrane normal, such
Fig. 3. Molecular architecture of FhuA and FepA. (A) Secondary structure representation of the plug domain of FepA. The TonB-box is colored purple. The
equivalent domain of FhuA shows a similar fold. (B) Secondary structure of the h-barrel of FhuA. Long loops are exposed to the solvent (top), whereas short
turns are directed toward the periplasm (bottom). FepA also presents a 22-stranded h-barrel of similar dimensions, although the extracellular loops of these
receptors differ markedly. An affinity-tag was inserted into L5 [8,11,12,14] and is shown in red.
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that its presence blocks the direct passage of siderophores
through the outer membrane. Two loops of the plug
domain of FepA extend approximately 20 A˚ beyond the
outer membrane interface [10]. FhuA has three equivalent
loops [apices A (R81), B (Q100) and C (Y116)] that are
important for ligand binding [8,9,11,12].
The plug domain also delineates two pockets within the
h-barrels of FhuA and FepA (Fig. 4A). Located above the
plug domain and open to the solvent is the conical-shaped
extracellular pocket. The electrostatic pocket linings for
these receptors are different, and are tailored to their
respective siderophores (ferrichrome is uncharged at phys-
iological pH, whereas ferric enterobactin is negatively
charged). A periplasmic pocket is found below the mixed
h-sheet of the plug domain and is exposed to the periplasm.
The N-termini of FepA (residues 1–10) and FhuA (residues
1–18) are localized to the periplasm, disordered, and could
not be modeled [8–12,14].
3. Ligand-binding site
The crystallographic structure of FepA in complex with
ferric enterobactin has not been described [10]. However,
structures of FhuA in complex with the siderophores ferri-
chrome [9], ferricrocin [8], phenylferricrocin [11], and the
antibiotics albomycin [11] and rifamycin CGP4832 [12] are
available (Table 1). Non-covalently bound within the extrac-
ellular pocket of FhuA and approximately 20 A˚ beyond the
outer membrane is a single ligand molecule. The iron
chelating portions of ferrichrome, ferricrocin, phenylferri-
crocin, and albomycin (all ferric hydroxamates) are bound
in identical orientations with the ferric ion buried, whereas
the peptide components of these siderophores remain sol-
vent-accessible within the extracellular pocket (Fig. 6). The
structure of FhuA in complex with the semi-synthetic
rifamycin derivative CGP4832 shows that this antibiotic
occupies a similar position within the extracellular pocket
Fig. 4. Crystallographic structures of unliganded FepA and unliganded FhuA. (A) These receptors are presented as found in the outer membrane with the
extracellular loops (top) and periplasmic turns (bottom) oriented toward the solvent and periplasm; and (B) View is given from the external solvent. The
h-barrels are colored blue (FhuA) and green (FepA), and the plug domains shown in yellow (FhuA) and orange (FepA).
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[12,15]. Although chemically dissimilar, these compounds
form electrostatic and van der Waals contacts with common
side chains from FhuA (Fig. 7 and Table 2). Within the plug
domain, apices A, B and C form most protein–ligand
interactions. Additional contacts between FhuA and its
ligand are provided by residues from the h-barrel located
in L3, L4, L5, L7, L8 and L11, and h7, h8, h9 and h10.
Given the structural diversity of these siderophores and
antibiotics, these data illustrate the limited structural specif-
icity of the binding site for this multifunctional transporter.
4. Ligand-induced structural changes
Binding of siderophores and antibiotics to the binding
site of FhuA induces local and allosteric transitions. Com-
paring the Ca-positions of unliganded FhuA to those of
FhuA liganded with ferricrocin [8], ferrichrome [9], phenyl-
ferricrocin [11], albomycin [11] or CGP4832 [12] reveals
near perfect superposition of the h-barrels. However, three
distinct plug domain conformations are observed: unli-
ganded, siderophore-liganded, and CGP4832-liganded.
Transition from the unliganded to siderophore-liganded
conformation causes local changes in the positions of the
Ca-atoms of apices A and B, illustrating an induced-fit
binding mechanism. Specifically, apices A and B move by
0.7–2.0 A˚ toward the siderophore, whereas apex C remains
stationary (Fig. 8). In the FhuA–CGP4832 complex, only
apex B is shifted vertically 0.5–1.5 A˚ toward the antibiotic,
apex A remains fixed, thereby establishing the CGP4832-
liganded conformation.
The upward translation of apex A is propagated to all
plug domain loops between this point and the periplasmic
pocket of FhuA. In the unliganded conformation, helix aA
termed the switch helix (residues 24–29) is positioned
within a cavity formed by the eighth and ninth periplasmic
turns, hA, and helix aB. Siderophore binding disrupts the
integrity of this cavity, causing all residues N-terminal of
R31 to undergo a helix-to-coil transition within the peri-
plasmic pocket (Fig. 8) (e.g. bending away from the previous
helix axis by 180j, W22 is displaced 17 A˚ from its
unliganded Ca-position). Apex A in the FhuA–CGP4832
complex remains fixed 4.6 A˚ away from the nearest ligand
atom, as in the unliganded conformation. No upward
movement of plug domain loops is induced, leaving the
switch helix wound. However, increases in the relative B-
Fig. 5. Crystallographic structure of FhuA in complex with lipopolysaccharide. A single E. coli K-12 lipopolysaccharide molecule was observed non-
covalently bound to the membrane-embedded surface of the receptor [14], and is shown as bond model with carbon atoms green, oxygen atoms red, nitrogen
atoms blue, and phosphorous atoms purple. The h-barrel and plug domain of FhuA are colored blue and yellow, respectively. Side chains forming the upper
and lower aromatic girdles are presented in orange.
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factors of the Ca-atoms composing the switch helix dem-
onstrate that this segment is destabilized upon CGP4832
binding.
5. Transmembrane signaling and TonB
Given that TonB-dependent receptors must compete for
a limited number of TonB molecules [16], the unwinding
of the switch helix functions as a tightly regulated, trans-
membrane signal that distinguishes unoccupied from occu-
pied outer membrane receptors. This pronounced allosteric
transition likely recruits TonB to its principal site of
known interaction with TonB-dependent receptors, the
TonB-box [17]. This N-terminal five-residue sequence
[TXXV(S/T); where X= hydrophobic side chain] is the
primary signature of TonB dependence [18,19].
Initial evidence suggesting that TonB associated with
the TonB-boxes of outer membrane receptors was provided
by genetic suppressor mutation studies. Bacterial cells
expressing TonB proteins with single amino acid substitu-
tions at position 160 were capable of restoring transport
activity to TonB-dependent receptors with altered TonB-
boxes [20–25]. Biochemical and biophysical techniques
later demonstrated that the TonB-boxes of outer membrane
transporters physically interact with TonB. When treated
with formaldehyde, FepA can be chemically cross-linked
to TonB [26]. The introduction of point mutations within
the TonB-box of FepA prevents cross-linking and the
TonB-dependent transport of ferric enterobactin in vivo
Fig. 6. Stereo representation of the binding sites for (A) ferricrocin; (B) phenylferricrocin; (C) albomycin; and (D) rifamycin CGP4832. The h-barrel is colored
blue and the plug domain yellow. Ligand molecules are shown as bond models with carbon atoms gray, oxygen atoms red, nitrogen atoms blue, sulfur atoms
green, and ferric ions as orange spheres. Protein– ligand hydrogen bonds are represented by dotted lines.
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[27]. Similar studies have been carried out with FhuA [28].
The three-dimensional structures of FhuA and FepA
revealed that the TonB-box is localized to the periplasm
[8–12,14]. Following this advance, site-directed disulfide
cross-linking was used to unequivocally demonstrate direct
physical interactions between the TonB-box of BtuB and
TonB [29]. Cysteine residues introduced at successive
positions within the TonB-box form disulfide bridges with
a single cysteine residue when inserted at or near to
position 160 of TonB [29,30].
Recent studies, in which the plug domains of FhuA and
FepA were genetically removed, showed residual TonB-
dependent activity for these mutant receptors [31,32]. In the
absence of the plug domain and the TonB-box, TonB
physically interacts with the h-barrel of FhuA and FepA.
Although secondary sites of interactions remain to be
determined, it is likely that an energized TonB molecule
interacts with at least one periplasmic turn, which drives
TonB-dependent siderophore transport [33].
6. TonB–ExbB–ExbD complex and energy
transduction
Different from solute transport across the cytoplasmic
membrane where primary or secondary energy-dependent
transporters utilize ion translocation or the hydrolysis of ATP
for uptake, there is no known energy source within the outer
membrane to drive the translocation of siderophores into the
periplasm. Thus, Gram-negative bacteria couple the chem-
iosmotic gradient of the cytoplasmic membrane with side-
rophore transport across the outer membrane [5]. Siderophore
uptake into the cytoplasm is mediated by periplasmic binding
protein-dependent ABC transporters. The division of ener-
Fig. 6 (continued).
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getic requirements reflects the compartmentalization of the
transport processes (Fig. 2). While the precise mechanism by
which chemiosmotic potential and ATP catalysis energize
transport remains to be determined, it is known that the
TonB–ExbB–ExbD complex is essential for the transfer of
energy to the outer membrane.
Alignment of Enterobacteriaceae tonB sequences identi-
fies three domains that contribute in distinct ways to TonB’s
function as an energy transducer [34,35]. The N-terminus of
TonB functions as an uncleaved export signal that anchors
the protein in the cytoplasmic membrane [36]. Although
deletion of this anchor does not inhibit the formation of
cross-linked FepA–TonB complexes [37], this segment is
required for energy transduction [38]. The second domain
contains proline-rich repeats. These motifs were predicted to
have functional significance as synthetic peptides corre-
sponding to this segment were shown by nuclear magnetic
resonance to be capable of spanning the periplasm [39,40].
However, deletion of this domain does not affect TonB
activity [41]. The structure of the C-terminal domain of
TonB was recently described; it forms a cylindrical-shaped
intertwined dimer that physically interacts with the TonB-
boxes of outer membrane receptors [42,43]. Genetic dele-
tion of this domain prevents formation of cross-linked
complexes of TonB with outer membrane receptors [44].
TonB’s association with the cytoplasmic membrane,
stability, and biological function is dependent upon two
additional membrane proteins with unusual transmembrane
topologies, ExbB and ExbD [45]. Different from TonB, the
N-terminus of ExbB is localized to the periplasm [46,47].
Two additional segments of this protein span the cytoplas-
mic membrane; the remainder resides in the cytoplasm [38].
Similar to TonB, ExbD is anchored in the cytoplasmic
membrane by its N-terminus; the remainder of the protein
Fig. 7. Schematic comparison of the hydrogen bonding pattern and charge interactions of (A) ferricrocin; (B) phenylferricrocin; (C) albomycin; and (D)
rifamycin CGP4832 with side chains of the FhuA ligand-binding site. The chemical structures of ferricrocin, phenylferricrocin, albomycin, and rifamycin
CGP4832 are shown with hydrogen bonds and charge interactions with side chains as dotted lines (distances are given in Angstrom units). Rifamycin
CGP4832 does not chelate iron.
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is largely placed in the periplasm [47]. In addition to
forming TonB –ExbB and TonB –ExbD complexes
[26,48–50], both ExbB and ExbD form oligomers in the
absence or presence of TonB and TonB-dependent receptors
[51]. In the absence of ExbB and ExbD, bacterial cells are
resistant to bacteriophage and group B colicin infection, and
manifest a 90% reduction in all TonB-dependent activities
[26,49]. The residual level of TonB activity results from the
presence of TolQ and TolR, which are functional analogues
of the ExbB and ExbD proteins of E. coli [52–55].
7. Transport across the outer membrane
By integrating currently available data, a model of TonB-
dependent siderophore transport can be proposed. TonB,
embedded within the cytoplasmic membrane, is closely
associated with the ExbB–ExbD complex. The binding of
siderophores to the extracellular pockets of outer membrane
receptors causes a TonB-independent allosteric transition
that is propagated through the outer membrane. The
unwinding of the switch helix and the translocation of the
TonB-box signal the occupancy of the receptor in the
periplasm.
The transfer of chemiosmotic potential from the cyto-
plasmic membrane to the outer membrane by the TonB–
ExbB–ExbD complex likely occurs by a cooperative tran-
sition. The ExbB–ExbD complex presumably constitutes
the entire proton translocation apparatus, which couples
chemiosmotic potential with a series of conformational
changes in TonB. Although ExbB has been shown to be
involved in this TonB-charging cycle, the role of ExbD
remains poorly defined [45,49,51,56]. Recently, it was
suggested that this cycle involves the transition of TonB
through three distinct conformations: uncharged, charged,
and discharged [45]. Following the unwinding of the switch
Fig. 7 (continued).
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helix and the transition to the liganded receptor conforma-
tion, one charged TonB molecule preferentially interacts
with outer membrane transporters [33,42,44]. However, a
population of uncharged TonB molecules may also form
binary complexes with liganded receptors with wound
switch helices as observed with the FhuA–CGP4832 com-
plex [14] and membrane fractionation studies [44,45]. In
either case, the C-terminal domain of TonB physically
contacts the TonB-box and probably other side chains found
within the periplasmic turns of the h-barrel domain of
TonB-dependent receptors [30,31]. This association occurs
independently of the energized state of TonB and the
ExbB–ExbD complex [33,42,44], but is enhanced by the
presence of ligand [26,28,29,42,56].
Upon forming a complex with an outer membrane
receptor, TonB releases stored energy, possibly in the form
of mechanical force, and assumes the discharged confor-
mation. The structural basis of this event remains to be
established. Energy transduction triggers an allosteric tran-
sition within the receptor such that binding site integrity is
disrupted, reducing the binding affinity. In vivo, formation
of a complex with TonB causes a high-conductance
channel to open within TonB-dependent receptors [57].
Cooperative structural changes within the plug domain
and/or h-barrel may eject the plug domain with bound
siderophore into the periplasm [58]. Alternatively, the plug
domain may remain inside the h-barrel, and both domains
undergo allosteric transitions leading to the opening of an
Fig. 7 (continued).
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underlying transmembrane channel within the receptor
through which the ligand permeates into the periplasm
by a surface-diffusion mechanism similar to those charac-
terized for glycoporins [8,59,60]. Upon arrival in the
periplasm, siderophores are rapidly bound by specific
periplasmic binding proteins, and shuttled to distinct
Fig. 7 (continued).
Table 2
Electrostatic and van der Waals contacts between FhuA and its cognate ligands bound in the extracellular pocket
Side chain Ferrichrome/
Ferricrocin
Phenylferricrocin Albomycina Albomycinb Rifamycin
CGP4832
R81—Apex A + + + + 
Y87—Plug domain  +   
E98—Apex B     +
G99—Apex B + + + + +
Q100—Apex B + + + + +
S101—Apex B     +
F115—Apex C  +  + +
Y116—Apex C + + + + +
Y244—L3 + + + + +
W246—L3 + + + + +
Y313—h7 + + + + +
Y315—L4 + + +  +
K344—h8   +  +
F391—h9 + + + + +
G392—h9     +
Y393—L5   + + 
Y423—h10    + +
Q505—L7    + +
F557—L8   +  
F558—L8   +  
F693—L11 + + + + +
Y696—L11     +
Listed are all side chains within 4 A˚ of ligand atoms: ferricrocin [8] or ferrichrome [9]; phenylferricrocin [11]; albomycin extended (a) and compact (b)
conformational isomers [11]; or rifamycin CGP4832 [14].
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ABC transporters embedded within the cytoplasmic mem-
brane for transport into the cytoplasm.
8. Unresolved questions
Although these multifunctional outer membrane recep-
tors provide structural platforms to study the complex
mechanism of TonB-coupled siderophore transport and
transmembrane signaling, the currently available data do
not clarify the precise mechanism of energy-dependent
transport through the outer membrane.
Before the solution of the three-dimensional structures
of FhuA and FepA, the h-barrels of these receptors were
predicted to actively participate in siderophore transport.
By analogy to the constriction loop of porins and their
putative role in voltage-gating, an equivalent extracellular
loop has been proposed to mediate channel opening and
closing by TonB-dependent receptors. Allosteric transitions
regulate channel formation, where siderophore binding and
the transfer of potential energy from TonB, modulate these
events. Gating refers to the process by which siderophore
binding to its receptor induces allosteric transitions that
enable transport by establishing or removing a physical
channel obstruction referred to as the gate, thereby regu-
lating transmembrane siderophore flow. However, compar-
ison of the unliganded and liganded FhuA structures does
not reveal any significant conformational changes within
the h-barrel upon the binding of siderophores or anti-
biotics. No movement or rearrangement of the extracellular
loops were observed, leaving the extracellular pocket of
FhuA open to the solvent. How can directed transport be
ensured in the absence of a gate that blocks the rerelease
of siderophore into the solvent? Can siderophore binding
cause allosteric transitions within the h-barrel in the
absence of TonB?
Fig. 8. Ligand-induced conformational changes in the plug domain of FhuA. The h-barrels of unliganded and liganded FhuA are shown as wire frame models.
The plug domain of unliganded FhuA is colored blue and liganded FhuA is shown in red [8,9].
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One siderophore-mediated iron acquisition system of E.
coli is responsive to both internal and external iron concen-
trations [61]. The outer membrane transporter of this system
(FecA) can be distinguished from FhuA and FepA as it
performs two independent functions: mediating ferric citrate
uptake and transcription of the ferric citrate transport genes
[62,63]. Excision of a linear segment of FecA termed the N-
terminal extension abrogates transcription; however, TonB-
dependent uptake of ferric citrate remains unaffected
[64,65]. Does FecA assume a similar molecular architecture
as FhuA and FepA? How can a two-domain arrangement
(barrel and plug) influence transcription in the cytosol? Is
the N-terminal extension an individual domain or an exten-
sion of the plug domain? Does ferric citrate binding to FecA
also cause local and allosteric transitions as observed with
FhuA? How is receptor occupancy signaled by the plug
domain and the N-terminal extension? What is the structural
basis of this signal transduction mechanism?
In conclusion, the determination of the three-dimensional
structures of FhuA and FepA provided a working model for
the TonB-dependent transport of siderophores across the
outer membrane; however, energy-dependent transitions
cannot be derived from crystallographic data. Thus, to fully
understand this energy-dependent transport mechanism will
require additional genetic, biochemical, and structural
experiments.
Note added in proof
Recently the crystal structures of the unliganded and
liganded forms of the outer membrane transporter FecA
were reported (A.D. Ferguson et al., Science 295 (2002)
1715–1719). Binding of ferric dicitrate to FecA causes
conformational changes near the TonB interaction site
similar to those seen in liganded FhuA; in addition, large
conformational changes in two extracellular loops of the
barrel domain lead to a complete closure of the ligand
blinding pocket.
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